Evidence map›Paper›PMID 21555634›Full record

Trial reportArchives of neurology2011

Test-retest reliability of memory task functional magnetic resonance imaging in Alzheimer disease clinical trials.

Alireza Atri, Jacqueline L O'Brien, Aishwarya Sreenivasan, Sarah Rastegar, Sibyl Salisbury, Amy N DeLuca, Kelly M O'Keefe, Peter S LaViolette, Dorene M Rentz, Joseph J Locascio and 1 more

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Archives of neurology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 41 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Fusiform correlates of facial memory in autism.Behavioral sciences (Basel, Switzerland) · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Alireza AtriMemory Disorders Unit, Massachusetts General Hospital, 15 Parkman Street, Wang Ambulatory Care Center 715, Boston, MA 02114, USA. atri@nmr.mgh.harvard.edu
Jacqueline L O'Brien
Aishwarya Sreenivasan
Sarah Rastegar
Sibyl Salisbury
Amy N DeLuca
Kelly M O'Keefe
Peter S LaViolette
Dorene M Rentz
Joseph J Locascio
Reisa A Sperling
United States Department of Veterans Affairs · USBrigham and Women's Hospital · USAthinoula A. Martinos Center for Biomedical Imaging · USMassachusetts General Hospital · US

Funding

THE ROLE OF ADVANCED CAA IN ALZHEIMER'S DEMENTIAP50AG005134 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI BETENSKY, REBECCA A. · 1985 to 2018
$42.1M
Evolution of memory-related fMRI activation over the course of MCI and ADR01AG027435 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI JOHNSON, KEITH A., SPERLING, REISA A. · 2006 to 2016
$8.6M
Mentoring Imaging Research in Early ADK24AG035007 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI SPERLING, REISA A. · 2010 to 2020
$1.4M
Modeling cholinergic modulation of fMRI memory networks in aging & MCIK23AG027171 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI ATRI, ALIREZA · 2006 to 2010
$805k
NIA NIH HHS 1K23 AG027171NIA NIH HHS 5 P50AG05134NIA NIH HHS K23 AG027171NIA NIH HHS K24 AG035007NIA NIH HHS P50 AG005134NIA NIH HHS R01 AG027435
6 · The paper itself

Abstract

objectiveTo examine the feasibility and test-retest reliability of encoding-task functional magnetic resonance imaging (fMRI) in mild Alzheimer disease (AD).

designRandomized, double-blind, placebo-controlled study.

settingMemory clinical trials unit.

participantsWe studied 12 patients with mild AD (mean [SEM] Mini-Mental State Examination score, 24.0 [0.7]; mean Clinical Dementia Rating score, 1.0) who had been taking donepezil hydrochloride for more than 6 months from the placebo arm of a larger 24-week study (n = 24, 4 scans on weeks 0, 6, 12, and 24, respectively).

interventionsPlacebo and 3 face-name, paired-associate encoding, block-design blood oxygenation level-dependent fMRI scans in 12 weeks.

main outcome measuresWe performed whole-brain t maps (P < .001, 5 contiguous voxels) and hippocampal regions-of-interest analyses of extent (percentage of active voxels) and magnitude (percentage of signal change) for novel-greater-than-repeated face-name contrasts. We also calculated intraclass correlation coefficients and power estimates for hippocampal regions of interest.

resultsTask tolerability and data yield were high (95 of 96 scans yielded favorable-quality data). Whole-brain maps were stable. Right and left hippocampal regions-of-interest intraclass correlation coefficients were 0.59 to 0.87 and 0.67 to 0.74, respectively. To detect 25.0% to 50.0% changes in week-0 to week-12 hippocampal activity using left-right extent or right magnitude with 80.0% power (2-sided α = .05) requires 14 to 51 patients. Using left magnitude requires 125 patients because of relatively small signal to variance ratios.

conclusionsEncoding-task fMRI was successfully implemented in a single-site, 24-week, AD randomized controlled trial. Week 0 to 12 whole-brain t maps were stable, and test-retest reliability of hippocampal fMRI measures ranged from moderate to substantial. Right hippocampal magnitude may be the most promising of these candidate measures in a leveraged context. These initial estimates of test-retest reliability and power justify evaluation of encoding-task fMRI as a potential biomarker for signal of effect in exploratory and proof-of-concept trials in mild AD. Validation of these results with larger sample sizes and assessment in multisite studies is warranted.

Indexed as

Magnetic Resonance ImagingMemoryNeuropsychological TestsAgedAged, 80 and overAlzheimer DiseaseCognition DisordersDouble-Blind MethodFeasibility StudiesFemaleHippocampusHumansMaleMemory DisordersMiddle AgedOxygenOxygen

Identifiers

PMID21555634
PMCPMC3291175
OpenAlexW2139191982

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.